{"product_id":"urologic-an-issue-of-salvage-therapies-for-non-muscle-invasive-bladder-cancer","title":"Urologic An issue of Salvage therapies for Non-Muscle Invasive Bladder Cancer","description":"\u003cspan data-mce-fragment=\"1\"\u003eTogether with Consulting Editor Dr. Samir Taneja, Dr. Badrinath Konety has put together a comprehensive issue that addresses Salvage therapies for Non-Muscle Invasive Bladder Cancer. Expert authors have contributed clinical review articles on the following topics: BCG salvage therapy: Definition and context; Who will respond to BCG? Predictors and nomograms; Identification of candidates for salvage therapy: Definition of BCG “Failure”; Predictors of response to Intravesical therapy; Precision medicine for NMIBC; Salvage therapy using BCG derivatives or single agent chemotherapy; Intravesical heated Mitomycin: Biology and clinical utility; Mitomycin derivatives in the salvage setting; Combination intravesical therapy; Intravesical gene therapy; Immunoncology as salvage therapy; Role of IDO inhibitors in salvage therapy; and Novel agents for intravesical therapy. Readers will come away with the clinical information they need to improve outcomes in patients with bladder cancer.\u003c\/span\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":44124805431534,"sku":"9780323722568","price":162.34,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/9612\/7726\/products\/9780323722568.jpg?v=1681374861","url":"https:\/\/bookland.com.au\/products\/urologic-an-issue-of-salvage-therapies-for-non-muscle-invasive-bladder-cancer","provider":"Book Land AU","version":"1.0","type":"link"}